about
Pathology of intrahepatic cholangiocarcinoma.Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in miceCD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinomaExpert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Surgical Therapy of Cholangiocarcinoma.Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series.Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.Common controversies in management of biliary strictures.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.Should we expand liver transplant criteria to cirrhotic patients with intrahepatic cholangiocarcinoma?Best option for preoperative biliary drainage in Klatskin tumor: A systematic review and meta-analysis.Endoluminal Nd:YAG laser application in ex vivo biliary porcine tissue.Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.Palliative Percutaneous Biliary Interventions in Malignant High Bile Duct Obstruction.No-Touch Concept Is Invalid for Left-Dominant Perihilar Cholangiocarcinoma.Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors.Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma.Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.Pancreaticoduodenectomy with Preservation of Collateral Circulation or Revascularization for Biliary Pancreatic Cancer with Celiac Axis Occlusion: A Report of 2 Cases.Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Efficacy of liver transplantation for hilar cholangiocarcinoma: A protocol for a systematic review and meta-analysisSurgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer CenterResection for Klatskin tumors: technical complexities and results
P2860
Q30235427-61466CA9-0C2F-46FB-A5A6-E12898F184CDQ33732027-5614E030-0EE0-4B67-999F-34F071985F64Q35839645-D2E9AF85-4757-4DC2-B956-34A53088F8BFQ36501683-78085C2E-C600-4FCD-912B-627BC3AB7390Q38621335-3206C435-F3F3-48C8-B048-08AC082FC4D4Q38812588-1200AA20-C240-4E1D-9BC7-2600E60D42BEQ39147323-BBC0B4BC-BE84-4E8A-AE21-CF504EFB369BQ39295269-71EA490F-24CA-4B02-9206-3EA63E64AB7AQ39754925-89C9A03B-EEDC-4003-83CE-AA3939C184A5Q40046782-59EDC2DC-3982-4AD3-9FE4-6B473F547F6DQ42320193-EEE35DB6-2142-49B6-BA2E-0C8E79C0F1B1Q46087686-37CBF98E-92F6-4AE0-9AAB-A1E9BAD4A4BDQ46246474-05DEBDCE-E5B9-4136-A068-044614AFA910Q47111318-D8C863BE-09DA-4D38-81AE-BA8CC2472581Q47135987-321926D4-DD70-4391-A188-12C50781DC1AQ47968679-79E61A65-BCDF-4BD0-A3C7-4CE84653EE9EQ48336081-4DB027FB-B9B3-4084-8D36-A505828B149DQ49711750-1AE700A3-CCF3-4DA5-833E-DE043EF8C8D6Q50013362-09CBF364-C7D6-4499-A2C1-4A08CFA4B0A2Q50076272-22C3E5E7-E332-4312-9885-E56D01919ADAQ52673102-EE7251A7-59A9-46F7-818E-8F8A8813835DQ52912098-88F668FB-DA6F-43B0-A988-4ED35CD64F37Q55018940-35640742-A473-4723-9BEA-7EF3D6294288Q55257627-E032356D-6639-49EC-8344-953DBE9EF69BQ55384365-0594EAFA-9495-4618-9C77-7529E513CCC8Q55431309-8F96789E-DFBA-4033-A4D1-F4279B791701Q57116040-A0E7D091-630D-4469-8426-2D1577162D66Q57116389-972FFC01-229E-4FFA-A1A0-64E9B71DBDF7Q58554189-A867C270-B363-412B-8D4D-72532929B9EB
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hilar cholangiocarcinoma: expert consensus statement.
@en
type
label
Hilar cholangiocarcinoma: expert consensus statement.
@en
prefLabel
Hilar cholangiocarcinoma: expert consensus statement.
@en
P2093
P2860
P356
P1476
Hilar cholangiocarcinoma: expert consensus statement.
@en
P2093
Christopher H Crane
John C Mansour
Julie K Heimbach
Masato Nagino
Thomas A Aloia
P2860
P304
P356
10.1111/HPB.12450
P577
2015-08-01T00:00:00Z